Rxcurve
HCPCS J0691 · per 1 MG

Inj lefamulin 1 mg

This code is not in the latest file (4Q26). It was last listed in 3Q23.

Payment limit per 1 MG, by effective quarter, 1Q21 to 3Q23. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J0691

No NDCs mapped to this code in the 4Q26 crosswalk.

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
3Q23 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted June 5, 2024
2Q23 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted February 23, 2024
1Q23 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted December 6, 2023
4Q22 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted June 22, 2023
3Q22 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted June 9, 2023
2Q22 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted December 14, 2022
1Q22 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted June 8, 2022
4Q21 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted June 2, 2022
3Q21 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted June 2, 2022
2Q21 $0.724 $0.00 1 MG Inj lefamulin 1 mg v1, posted March 1, 2022
1Q21 $0.724 – 1 MG Inj lefamulin 1 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files